Tags |
|
|
Links |
|
|
Answers - Your Mortgage Endowment - Cash In Or Continue?
Many new clients we meet have one or two unitised with profits endowments in their investment portfolio. Whilst some have decided that there may be better alternatives available for their mon
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ey after years of falling returns (and questionable prospects), many are hanging on in the belief that things could take a turn for the better.
If you have one or more of these plans, what S
If you have one or more of these plans, what S
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
OULD you do?
Indeed, what CAN you do could be one of your main questions.
The reality is that the annual returns on 'unitised' with profits investments have been falling for the last 9 year
Indeed, what CAN you do could be one of your main questions.
The reality is that the annual returns on 'unitised' with profits investments have been falling for the last 9 year
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
.
NOTE: There are other types of endowment policies including Full Cost Guaranteed, Traditional With Profits and Unit-Linked plans. This article does NOT apply to these plans.
The way in wh
NOTE: There are other types of endowment policies including Full Cost Guaranteed, Traditional With Profits and Unit-Linked plans. This article does NOT apply to these plans.
The way in wh
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ch the unitised with profits plans work is that when your monthly premium is received by the insurance company, a percentage pays for charges and the remainder is split between paying for the
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
life assurance/critical illness insurance and the actual investment.
The investment portion is split between:
- shares
- property
- bonds
- cash
With profits funds were desi
The investment portion is split between:
- shares
- property
- bonds
- cash
With profits funds were desi
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
gned to 'smooth out' the returns of the stockmarket. In years of good returns the insurance company would retain a portion of the profit and pay an annual bonus to your plan.
In years of poo
In years of poo
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
returns the theory is that they would dip into their reserves and pay an annual bonus. Once these bonuses have been paid they cannot be removed.
If the insurance company you have your plan
If the insurance company you have your plan
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ith is not financially strong, it's likely that they will be investing a higher proportion of your money in fixed interest (bonds) and cash, restricting potential future growth. Over the last
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
10 years many companies have been increasingly moving the money in their with profits funds towards bonds and cash.
So if the returns on your plan have been falling every year, and more of t
So if the returns on your plan have been falling every year, and more of t
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
e money has moved OUT of shares, you don't have to be a genius to work out that future prospects may not be great.
If the company you are with is financially strong, you'll be ok, surely?
M
If the company you are with is financially strong, you'll be ok, surely?
M
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
aybe not.
Norwich Union is a strong with profits office and they have 43% of the money in their with profits fund invested in shares. Even so, the company predict that only one in ten of the
Norwich Union is a strong with profits office and they have 43% of the money in their with profits fund invested in shares. Even so, the company predict that only one in ten of the
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
r 750,000 endowment policyholders will receive the original target sum at the end of the policy term.
The fund actually returned 10.7% in 2006. Even so, the company has REDUCED payouts on ma
The fund actually returned 10.7% in 2006. Even so, the company has REDUCED payouts on ma
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
y plans that matured in 2006. They will be further reduced in 2007 by many companies.
Let's look at some actual payouts for a male aged 29, investing ?50 pm over 25 years.
In 1988, Norwich
Let's look at some actual payouts for a male aged 29, investing ?50 pm over 25 years.
In 1988, Norwich
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
nion paid out ?100,247. Not bad for a total investment of ?15,000.
By 2006 this figure had fallen to ?45,338. In 2007 the figure is ?42,133.
If you are with a financially weak provider, suc
By 2006 this figure had fallen to ?45,338. In 2007 the figure is ?42,133.
If you are with a financially weak provider, suc
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
as Scottish mutual and NPI, the situation could be even worse.
The Future
So what options do you have?
Whilst there is no simple answer, as every situation is different, you can:
- conti
The Future
So what options do you have?
Whilst there is no simple answer, as every situation is different, you can:
- conti
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
nue with the plan and receive the proceeds when it matures
- stop investing into the plan and receive the proceeds when it matures (and perhaps invest the money elsewhere or pay down your mo
- stop investing into the plan and receive the proceeds when it matures (and perhaps invest the money elsewhere or pay down your mo
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
tgage)
- cash in/surrender the plan and invest/pay down
There are pros and cons to all these (such as the loss of life cover) so you really do need to do your research before you take any a
- cash in/surrender the plan and invest/pay down
There are pros and cons to all these (such as the loss of life cover) so you really do need to do your research before you take any a
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
tion.
The Financial Tips Bottom Line
If you do have an endowment plan, please don't make the mistake of buying your head in the sand and ignoring the facts. For example, if you're paying ?1
The Financial Tips Bottom Line
If you do have an endowment plan, please don't make the mistake of buying your head in the sand and ignoring the facts. For example, if you're paying ?1
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
0 pm into a plan with 8 years to run, you'll be handing the insurance company ?9,600.
Find out what the best option is for YOU, and have the peace of mind that you've made the right decision
Find out what the best option is for YOU, and have the peace of mind that you've made the right decision
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/102224/answers-Your-Mortgage-Endowment--Cash-In-Or-Continue.html">Your Mortgage Endowment - Cash In Or Continue?</a>
BB link (for phorums):
[url=http://www.answers.org.ua/article/102224/answers-Your-Mortgage-Endowment--Cash-In-Or-Continue.html]Your Mortgage Endowment - Cash In Or Continue?[/url]
Related Articles:
PR: The Wildcard Marketing Strategy
Sales Leads: Maximize Your Sales With Longer-Term Sales Leads
Bookmark it:
|